Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.431
+0.001 (0.05%)
Nov 21, 2024, 10:40 AM EST - Market open
Compugen Employees
Compugen had 68 employees as of December 31, 2023. The number of employees decreased by 1 or -1.45% compared to the previous year.
Employees
68
Change (1Y)
-1
Growth (1Y)
-1.45%
Revenue / Employee
$880,176
Profits / Employee
$23,515
Market Cap
128.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Coherus BioSciences | 306 |
Zomedica | 144 |
Adverum Biotechnologies | 121 |
Candel Therapeutics | 42 |
Cardiff Oncology | 32 |
Eupraxia Pharmaceuticals | 29 |
Fennec Pharmaceuticals | 29 |
Zentek | 24 |
CGEN News
- 8 days ago - Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Compugen Reports Third Quarter 2024 Results - PRNewsWire
- 10 days ago - Compugen to Participate in Stifel 2024 Healthcare Conference - PRNewsWire
- 16 days ago - Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024 - PRNewsWire
- 23 days ago - Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - PRNewsWire
- 6 weeks ago - Compugen to Present New Clinical Data at SITC 2024 - PRNewsWire
- 2 months ago - Compugen to Present at Single Cell Genomics 2024 Conference - PRNewsWire
- 3 months ago - Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire